The trend of scientific publications in drug discovery in Australia from 2013 to 2023 demonstrates a notable fluctuation. The number of publications ranged from a low of 94.9 in 2017 to a high of 119.43 in 2015. The year-on-year variation illustrates significant volatility, with a drop of 1.54% in 2014, a peak rise of 9.18% in 2015, and a considerable decline of 19% in 2017. This fluctuation is mirrored in the average annual CAGRs, which show negative values for many years, especially reaching -4.33% in 2020 and -2.75% in 2021.
Remarkably, the number in 2023 stood at 101.06 publications, indicating a slight year-on-year increase of 0.22%. Future projections show a relatively stable upward trajectory with modest growth rates, resulting in a forecasted 5-year CAGR of 0.08% by 2028.
Future trends to watch for include the impact of increased funding for drug discovery research, the influence of global collaborations, and the adoption of advanced technologies which could spur a notable increase in publications. Additionally, monitoring policy shifts and their potential to either bolster or hinder research outputs will be crucial.
